Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Recurrence 2Pancreatic Neoplasms 2Neoplasms 2Lymphoma, B-Cell 2Hematologic Neoplasms 2Sarcoma 1Ovarian Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Metastatic Solid Tumors 1Mesothelioma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Hemorrhage 1Hematologic Diseases 1Head and Neck Neoplasms 1Gynecological Solid Tumors 1Fallopian Tube Neoplasms 1Diarrhea 1Colitis 1Childhood Solid Tumor 1

Interventions

Sorafenib 42Bevacizumab 26Oxaliplatin 21Radiosurgery 19Gemcitabine 17Fluorouracil 15Hepatectomy 13lenvatinib 12Radiofrequency Ablation 11Nivolumab 11Cisplatin 11Radiotherapy 10Doxorubicin 10Capecitabine 10durvalumab 9Leucovorin 9Blood Specimen Collection 9atezolizumab 8Liver Transplantation 8Everolimus 7Electroporation 7pembrolizumab 6camrelizumab 6Sunitinib 6Immunohistochemistry 6Cryosurgery 6Carboplatin 6tremelimumab 5sintilimab 5apatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Liver Neoplasms × Cell- and Tissue-Based Therapy × Clear all
NCT06196294 2024-06-26

GPC3/Mesothelin-CAR-γδT Cells Against Cancers

Second Affiliated Hospital of Guangzhou Medical University

Phase 1 Recruiting
30 enrolled
GastrointestinalOther solid neoplasmThoracic

Liver Neoplasms, Lung Neoplasms, Mesothelioma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡